Published: August 1, 2024

Reg-ent Registry: Building on Milestones and Focused on the Future

Academic and private practice centers across the country are taking advantage of the many benefits of Reg-ent.


Reg EntEarlier this year, the Reg-ent registry crossed an important milestone, thanks to increasing participation by new and previously registered practices—exceeding over 50 million recorded visits by 10 million unique patients from over 1,500 providers at both academic and private practice centers. This incredible resource is now facilitating public quality reporting, outcomes and clinical research, product surveillance, and continuing certification. Here, we highlight opportunities for participants (and prospective participants) to benefit from using Reg-ent for CMS quality reporting and conducting their own data-led research.

If you are interested in signing up or have questions about Reg-ent, reach out to the AAO-HNSF Reg-ent team at reg-ent@entnet.org.

Quality Measures

The Reg-ent registry remains a crucial support system for CMS quality reporting, benefiting many of our participants and their practices, regardless of their practice size and institution. As highlighted in the July issue of the Bulletin, the Reg-ent team conducted a retrospective analysis of the Quality Payment Program (QPP) experience report to study the performance of Reg-ent participants versus nonparticipants.

On average, Reg-ent participants received a 3.91% incentive, surpassing non-Reg-ent participants earning 2.31%. Specifically for unweighted otolaryngology quality scores, Reg-ent participants averaged 79 points compared with 54 points for otolaryngologists not reporting through Reg-ent. Although most Reg-ent participant are otolaryngologists, the registry also offers benefits for audiologists, allergists, and nurse practitioners. All the clinician types participating in Reg-ent achieved a significantly higher score in MIPS 2022 reporting compared with their non-Reg-ent peers in all three categories supported by Reg-ent. The graphs below show the results achieved by Reg-ent participants and nonparticipants for final scores and payment averages.

Results achieved by Reg-ent participants versus nonparticipants for final scores and payment averages.Results achieved by Reg-ent participants versus nonparticipants for final scores and payment averages.

Download Image


With successful reporting cycles for MIPS, Reg-ent is geared up for MVP reporting starting this year. CMS has approved the MVP specific to otolaryngology starting this year, and the Reg-ent team is working with member practices to help them with the transition. The MVP focuses on caring for patients experiencing some of the most common otolaryngology conditions such as otologic conditions, chronic rhinosinusitis, age-related hearing loss, and otitis media.

With more than 25% of the total measure set consisting of qualified clinical data registry (QCDR) measures, Reg-ent participants enjoy the benefit of selecting measures applicable to their practice specialty without being limited to a small selection. The Reg-ent team is ready to discuss and help member practices navigate this new process of registration, selection and reporting of MVPs.

Reg-ent’s Research Capabilities: Recent and Upcoming Projects

Physicians are increasingly realizing how data can be used in more meaningful and efficient ways to support their practice. Likewise, Reg-ent participants are engaging with their data to conduct research on clinical topics of interest. Earlier this year, a pilot study to evaluate changes in the volume and practice-setting of laryngology procedures during the COVID-19 pandemic was published in the journal OTO Open. The Reg-ent Research Advisory Group (RRAG) welcomes your proposals for future studies.

Using the data studio, the AAO-HNSF Reg-ent team has been exploring the registry’s data on key clinical topics to produce valuable insights. As discussed in the July issue of the Bulletin, the Reg-ent team recently studied trends in post-tonsillectomy opioid prescription in patients aged 4 to 18 years to elucidate compliance with the 2019 update to the Clinical Practice Guideline on “Tonsillectomy in Children,” which recommends against the use of post-treatment opioids for pain relief. Similarly, we are now exploring disparities in the treatment of presbycusis based on demographic factors (e.g., race, ethnicity, gender, age, and geographic region) as a follow-up to the CPG “Age-Related Hearing Loss,” published earlier in 2024. A third study using the registry’s data explores the frequency of balloon sinuplasty versus functional endoscopic sinus surgery.

The Reg-ent team is all set to showcase these findings during the AAO-HNSF 2024 Annual Meeting & OTO EXPO in Miami Beach, Florida. We invite all Annual Meeting attendees to visit the Reg-ent booth in the OTO EXPO hall and experience our dynamic and interactive PowerBI dashboards. An agenda of daily presentations will also be available on a digital display at the Research and Quality booth in the Academy Central area, located in the Grand Lobby, during the Annual Meeting.

Not registered yet? Be sure to secure your spot today!


More from August 2024 – Vol. 43, No. 8